Related Experiment Video
Updated: Jun 10, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Probiotics for prevention of necrotising enterocolitis: an updated meta-analysis
F Guthmann1, C Kluthe, C Bührer
1Klinik für Neonatologie, Charité Universitätsmedizin Berlin, Germany. florian.guthmann@charite.de
Insights
Prophylactic probiotics significantly reduce necrotizing enterocolitis (NEC) and mortality in preterm infants. Studies show these beneficial bacteria are safe and effective for vulnerable newborns.
Area of Science:
- Neonatal Medicine
- Microbiology
- Clinical Trials
Background:
- Necrotizing enterocolitis (NEC) is a major cause of mortality in preterm infants.
- Prophylactic probiotic use has been investigated to reduce NEC rates.
- Previous meta-analyses exist, but recent trials offer updated insights.
Purpose of the Study:
- To evaluate the efficacy and safety of prophylactic probiotics in preterm infants at risk for NEC.
- To synthesize evidence from existing meta-analyses and recent randomized controlled trials (RCTs).
- To determine the impact of probiotics on NEC incidence and mortality.
Main Methods:
- Meta-analysis of multiple randomized controlled trials (RCTs) investigating prophylactic probiotic use.
- Analysis of three subgroups: common RCTs, previously included RCTs, and recent RCTs.
- Calculation of relative risk (RR) for NEC (Bell stage ≥2) and mortality.
Main Results:
- Consistent reduction in NEC rates (RR 0.35) and mortality (RR 0.41) across all meta-analysis approaches.
- NEC and mortality rates align with North American and European network data.
- Optimal outcomes observed with multi-species probiotics, including Bifidobacterium spp. and Lactobacillus acidophilus.
- No adverse side effects reported in 1,117 infants receiving probiotics.
Conclusions:
- Prophylactic probiotics are safe and beneficial for preterm infants at risk of NEC.
- The use of specific probiotic combinations may enhance efficacy.
- Evidence supports the integration of probiotics into neonatal care protocols for NEC prevention.
Abstract:
Several randomized controlled trials (RCTs) have investigated the prophylactic use of probiotics in preterm infants aimed at reducing the rate of necrotising enterocolitis (NEC). There are 4 meta-analyses on this subject. 2 more RCTs have been published since these meta-analyses were completed. Each meta-analysis, as well as the 2 recent RCTs, document reduced rates of NEC and mortality with the use of prophylactic probiotics. We calculated meta-analyses based on 3 approaches: A - RCTs common to all meta-analyses, B - RCTs ever accounted for in a meta-analysis but not common to all, and C - the 2 recent RCTs. The 3 subgroups yield similar results, with an overall reduction in the relative risk (RR) of NEC (Bell > or =2) to 0.35 (95% CI 0.23-0.55) and of mortality to 0.41 (0.28-0.60). NEC rates and mortalities in the dominant RCTs are in the range reported from North American and European networks. Best results appear to be achieved with probiotics based on 2 or more probiotic species and/or with a combination of Bifidusbacterium spp. and Lactobacillus acidophilus. No unwanted side effects have been reported among 1 117 infants randomized to receive probiotics. We conclude that probiotics are safe and beneficial in preterm infants at risk for NEC.
More Related Videos
Related Concept Videos
Probiotics
Microbiota Modulation by Antibiotics
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Development of Human Microbiota
Development of the Oral Microbiota
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

